Table 1.

HLA data on NK and tumor cells used in experiments



NK cells

Tumor cells

HLA class I

HLA-C group homozygous

RCC
MEL
LCL
A
B
Cw
R   -   -   +   +   02, 23   15, 35   02, 04   2  
St   +   -   +   +   02, 29   07, 08   0701, 0702   1  
Wh   -   +   -   -   03, 01   08, 44   05, (-)  2  
SJ   -   +   -   +   11, 11   51, 55   01, 0303   1  
Volle   -   -   -   +   02, 03   07, 51   01, 0702   1  
KR0350   +   -   -   +   02, 68   40, 44   0304, 0704   1  
SKEM*  +   -   -   -   11, 11   51, 55   01, 0303   1  
MORRC
 
+
 
-
 
-
 
-
 
02, 11
 
35, 40
 
02, 04
 
2
 


NK cells

Tumor cells

HLA class I

HLA-C group homozygous

RCC
MEL
LCL
A
B
Cw
R   -   -   +   +   02, 23   15, 35   02, 04   2  
St   +   -   +   +   02, 29   07, 08   0701, 0702   1  
Wh   -   +   -   -   03, 01   08, 44   05, (-)  2  
SJ   -   +   -   +   11, 11   51, 55   01, 0303   1  
Volle   -   -   -   +   02, 03   07, 51   01, 0702   1  
KR0350   +   -   -   +   02, 68   40, 44   0304, 0704   1  
SKEM*  +   -   -   -   11, 11   51, 55   01, 0303   1  
MORRC
 
+
 
-
 
-
 
-
 
02, 11
 
35, 40
 
02, 04
 
2
 

HLA-C group patients are grouped according to HLA-C alleles and corresponding KIR ligands.

*

SKEM is an HLA-identical sibling donor for RCC patient SJ.

Wh-RCC lost an HLA-Cw locus.

or Create an Account

Close Modal
Close Modal